Development of 99mtc-hynic-adh-1 molecular probe specifically targeting n-cadherin and its preliminary experimental study in monitoring drug resistance of non-small-cell lung cancer

HIGHLIGHTS

• who: Qianni Ye and collaborators from the Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China have published the paper: Development of 99mTc-Hynic-Adh-1 Molecular Probe Specifically Targeting N-Cadherin and Its Preliminary Experimental Study in Monitoring Drug Resistance of Non-Small-Cell Lung Cancer, in the Journal: Cancers 2023, 15, 755. of 26/01/2023
• what: In this study a novel molecular imaging probe 99m TcHYNIC-ADH-1 was developed and diagnostic value in monitoring drug resistance in NSCLC was preliminarily investigated. The research demonstrated the high targeting . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.